LPL Financial LLC Grows Stock Holdings in iShares Biotechnology ETF $IBB

LPL Financial LLC increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 145.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 992,799 shares of the financial services provider’s stock after buying an additional 589,033 shares during the quarter. LPL Financial LLC’s holdings in iShares Biotechnology ETF were worth $167,555,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in IBB. Brighton Jones LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at $201,000. AQR Capital Management LLC acquired a new stake in iShares Biotechnology ETF during the 1st quarter valued at $455,000. Millennium Management LLC grew its holdings in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares in the last quarter. M&T Bank Corp grew its holdings in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock valued at $337,000 after purchasing an additional 750 shares in the last quarter. Finally, Walleye Capital LLC grew its holdings in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after purchasing an additional 985 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 2.0%

IBB opened at $165.93 on Thursday. The company has a fifty day simple moving average of $170.24 and a 200 day simple moving average of $170.63. iShares Biotechnology ETF has a twelve month low of $123.61 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.